ICIG Kicks Off €50 Million Investment at PPC in Thann

PPC, a company of WeylChem Group, the fine chemicals platform of International Chemical Investors Group (ICIG), has secured bank financing from Commerzbank for the conversion of the mercury electrolysis plant. The equity portion of the financing will be provided by ICIG.

PPC will convert its production of Chlorine and Potassium derivatives via a mercury based electrolysis to membrane technology. This project is expected to last 28 months. Due to its environmental side effects, mercury based technology will be prohibited by French regulation after the year 2019. In parallel, PPC is to carry out an upgrade and extension of the current bromine recovery capabilities on site which should lead to significant cost savings for bromine. The duration of this project is expected to be 24 months. The total investment for both projects will be €53 million.

Chemieanlagenbau Chemnitz ("CAC") has been selected to build the new membrane electrolysis plant and the bromine recovery plant for PPC. CAC has extensive experience in the segment of erection, re-vamping and expanding electrolysis plants.

As per French regulation, this project is subject to consultation by PPC's work council.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.